Sims EK, Cuthbertson D, Herold KC, Sosenko JM, et al. The Deterrence of Rapid Metabolic Decline within 3 Months after Teplizumab
Treatment in Individuals at High Risk for Type 1 Diabetes. Diabetes 2021 Sep 22. pii: db21-0519. doi: 10.2337/db21-0519.
PMID: 34551936